The company was founded in 2017 to guarantee patients in Germany access to medical cannabis of the highest pharmaceutical quality. In May 2019, the Federal Institute for Drugs and Medical Devices (BfArM) awarded DEMECAN the contract for the cultivation of medical cannabis (more). From 2020 DEMECAN will supply the Federal Republic of Germany with medical cannabis. The DEMECAN group is based in Berlin. The cultivation and processing of medical cannabis is carried out in a second facility near Dresden. DEMECAN also imports medical cannabis to Germany as a pharmaceutical wholesaler.